Product Program year 2021 Source: CMS Open Payments

Durata Defibrillation ICD Lead

Device Cardiac Rhythm Management

PDI 05414734505130

Open in the dashboard

General payments

$10,739

356 payments

Research payments

$1,075

2 payments

Through program year 2021, $10,739 in general payments and $1,075 in research payments were reported against Durata Defibrillation ICD Lead (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $10,739 356
2021 Research $1,075 2

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $10,739 356 payments
Top recipients General payments · program year 2021
  1. David Burkland Clinical Cardiac Electrophysiology · Houston, TX $249 2% · 2 payments
  2. Enrique Huertas Cardiovascular Disease · Miami, FL $185 2% · 2 payments
  3. Michele Sartori Interventional Cardiology · Houston, TX $184 2% · 1 payment
  4. Brian Greet Clinical Cardiac Electrophysiology · Houston, TX $184 2% · 1 payment
  5. Daniel Alvarez Cardiovascular Disease · Wichita, KS $172 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $3,414 32% · 58 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $3,019 28% · 61 practitioners
  3. Interventional Cardiology Internal Medicine $1,166 11% · 43 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $736 7% · 19 practitioners
  5. Physician Assistant $522 5% · 11 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $2,180 20% · 46 recipients
  2. Florida $1,283 12% · 18 recipients
  3. Kansas $1,106 10% · 10 recipients
  4. New York $1,080 10% · 21 recipients
  5. Missouri $1,071 10% · 36 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

356 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record